Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET.

Sakellaropoulos, Stefanos G; Ali, Muhammad; Papadis, Athanasios; Mohammed, Muhemin; Mitsis, Andreas; Zivzivadze, Zaza (2022). Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET. Cardiology research, 13(5), pp. 264-267. Elmer Press 10.14740/cr1419

Preview

Text 1419-9565-1-PB.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (756kB) | Preview

The new outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has an impact worldwide, primarily as a medical emergency. Even that the total constellation is considered as a pandemic of acute respiratory disease, coronavirus disease 2019 (COVID-19) gives rise to dysfunction in multiple organs (e.g., brain, lungs, heart, muscles) that impairs cardiopulmonary (CP) function. Parallel to the CP consequences of COVID-19 is a significant reduction in physical activity. Cardiopulmonary exercise testing (CPET) is daily used in clinical practice to define prognosis, provide risk stratification and treatment strategy. As such, the significance of CPET is crucial concerning clinical assessments of COVID-19 patients. Furthermore, new studies aim at understanding the effects of SARS-CoV-2 infection in long term. Multiple studies have investigated the cardiopulmonary function and impairment of exercise endurance in such patients, as well as a possible prolonged physical impairment. With this review, we summarize the COVID-19-associated pathophysiology for the Long COVID (LC) syndrome as well as the importance of performing CPET.

Interest & Impact

Downloads

40 since deposited on 23 Nov 2022
26 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item